BerandaAVH • ASX
add
AVITA Medical Inc
Tutup sebelumnya
$2,71
Rentang hari
$2,76 - $2,85
Rentang tahun
$2,34 - $5,12
Kapitalisasi pasar
371,77Â jt AUD
Volume Rata-Rata
179,37Â rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 18,41Â jt | 29,67% |
Biaya operasional | 26,08Â jt | 5,72% |
Laba bersih | -11,59Â jt | -64,03% |
Margin laba bersih | -62,96 | -26,50% |
Penghasilan per saham | -0,70 | -63,16% |
EBITDA | -9,55Â jt | 21,00% |
Tarif pajak efektif | -0,16% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 35,88Â jt | -59,71% |
Total aset | 79,71Â jt | -28,60% |
Total liabilitas | 75,21Â jt | 20,18% |
Total ekuitas | 4,50 jt | — |
Saham yang beredar | 26,36 jt | — |
Harga terhadap nilai buku | 15,94 | — |
Tingkat pengembalian aset | -30,97% | — |
Tingkat pengembalian modal | -45,95% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -11,59Â jt | -64,03% |
Kas dari operasi | -8,08Â jt | 25,61% |
Kas dari investasi | 2,47Â jt | 104,31% |
Kas dari pembiayaan | 1,02Â jt | -97,41% |
Perubahan kas bersih | -4,59Â jt | 84,03% |
Arus kas bebas | -133,69Â jt | 72,74% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
260
